MRK vs INCY
By Alex · Tickerpine
Merck & Co., Inc. vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | INCY |
|---|---|---|
| Price | $148.69 | $124.82 |
| Market cap | $366.84B | $25.30B |
| P/E ratio | 119.0 | 15.8 |
| ROE | 6.96% | 30.67% |
| Profit margin | 4.77% | 27.71% |
| Revenue growth | 5.10% | 37.70% |
| Dividend yield | 2.29% | — |
| Beta | 0.23 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs INCY in plain English
- MRK is the bigger company — about 14.5× the market cap of INCY.
- INCY is cheaper on earnings (P/E 15.8 vs 119.0).
- INCY earns a higher return on equity (31% vs 7%).
- INCY is growing revenue faster (38% vs 5%).
- MRK pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.